Rutgers School of Public Health associate professor, Dr. Henry F. Raymond, has been selected to serve on the U.S. Food and Drug Administration’s (FDA) steering and monitoring committee for the HIV Risk Questionnaire (HRQ) study.
Currently the FDA’s “Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products” policy states, that men who have had sex with men within the past 12 months have a deferral period of 12 months before they are eligible to donate blood. This discrimination has caused a stir in the LGBTQ+ (lesbian, gay, bisexual, transgender and queer/questioning and others) community.
The study was designed to assess potential risk of alternative Men Who Have Sex with Men (MSM) donor deferral strategies and to provide evidence by which to consider potential changes, such as reducing or eliminating the MSM deferral policy while maintaining the safety of the blood supply.
The HRQ seeks to do this by providing a series of behavioral history questions that will help to predict recent infection with human human immunodeficiency virus (HIV) in MSM who are interested in donating blood.
“This study is the next step in improving our blood donation guidelines to ensure safe and robust blood supply while allowing as many donors as possible to participate in a system that relies on altruism,” said Dr. Raymond.Tags: Friday Letter Submission, Publish on February 07